Article Listing

FDA News
Feb 11, 2020
The U.S. Food and Drug Administration (FDA) has approved the use of Sabril® (vigabatrin) for use in people with refractory or drug-resistant focal epilepsy in people 2 years of age and older. It is intended to be used in addition to other ...
300 million people living with a rare disease around the world
Feb 9, 2020
On February 29, 2020, the Epilepsy Foundation will join hundreds of patient organizations from around the world for Rare Disease Day. Held on the last day of February each year, Rare Disease Day raises awareness among the general public and key...
Anchorage, Alaska
Feb 4, 2020
We are shining a spotlight on the Epilepsy Foundation’s efforts to provide education about epilepsy care to advanced practice providers (physician assistants and nurse practitioners) in Alaska. Reaching these rural communities is critical. Alaska...
webinar
Feb 2, 2020
Webinar on Wednesday, February 26, 2020, from 8:00 to 9:00 p.m. ET Register Here   Join us for an educational webinar, #KnowYourEpilepsy, on February 26, 2020. Understanding your diagnosis of epilepsy is critical to having good communication...
Co-founder of Curadite, Jody McNannay.
Jan 28, 2020
Jody McNannay is the co-founder of Curadite, a medication management platform incorporating intelligent packaging, patient reminders, and a clinician dashboard for the epilepsy community. This past year, Curadite was awarded an Epilepsy Foundation...

Our Mission

The mission of the Epilepsy Foundation is to lead the fight to overcome the challenges of living with epilepsy and to accelerate therapies to stop seizures, find cures, and save lives.

 
24/7 helpline